Mike Kuranda
Impact in
-
- Antibiotic Resistance in Bacteria
-
- Microbial Natural Products and Biosynthesis
Papers in
-
- Melanoma and MAPK Pathways 2
- Ubiquitin and proteasome pathways 2
- RNA and protein synthesis mechanisms 1
- DNA Repair Mechanisms 1
-
- Computational Drug Discovery Methods 2
- Co-authors
- Zhi‐Dong Jiang (2 shared papers)Maureen T. DeCenzo (2 shared papers)David M. Rothstein (2 shared papers)Michael D. Pickard (1 shared paper)Nagraj Mani (1 shared paper)Jonathan L. Blank (2 shared papers)Michael P. Thomas (1 shared paper)Darshan S. Sappal (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)The Journal of Antibiotics (2 papers)Journal of Clinical Oncology (1 paper)Analytical Biochemistry (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Mike Kuranda
7 papers receiving 103 citations
Peers
Comparison fields: 5 of 37
- Molecular Medicine 20
- Pharmacology 22
- Molecular Biology 77
- Oncology 29
- Microbiology 5
Countries citing papers authored by Mike Kuranda
This map shows the geographic impact of Mike Kuranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Kuranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Kuranda more than expected).
Fields of papers citing papers by Mike Kuranda
This network shows the impact of papers produced by Mike Kuranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Kuranda. The network helps show where Mike Kuranda may publish in the future.
Co-authors
The 25 scholars most cited alongside Mike Kuranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 45 | |
| 2 | 1998 | 30 | |
| 3 | 2002 | 21 | |
| 4 | 2010 | 10 | |
| 5 | 2013 | 1 | |
| 6 | 2015 | 1 | |
| 7 | 2013 | 1 |
About Mike Kuranda
Mike Kuranda is a scholar working on Molecular Biology, Computational Theory and Mathematics, Organic Chemistry, Pharmacology and Pathology and Forensic Medicine, having authored 7 papers that have together received 109 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (2 papers), Melanoma and MAPK Pathways (2 papers), Ubiquitin and proteasome pathways (2 papers), RNA and protein synthesis mechanisms (1 paper), Bacterial Genetics and Biotechnology (1 paper), Microbial Natural Products and Biosynthesis (1 paper), DNA Repair Mechanisms (1 paper) and Enzyme Production and Characterization (1 paper). The work is most often cited by research in Molecular Medicine (20 citations), Pharmacology (22 citations), Molecular Biology (77 citations), Oncology (29 citations) and Microbiology (5 citations). Mike Kuranda has collaborated with scholars based in United States and Japan. Frequent co-authors include Zhi‐Dong Jiang, Maureen T. DeCenzo, David M. Rothstein, Michael D. Pickard, Nagraj Mani, Jonathan L. Blank, Michael P. Thomas, Darshan S. Sappal, Greg Hather and Ray Liu. Their work appears in journals such as Molecular Cancer Therapeutics, The Journal of Antibiotics, Journal of Clinical Oncology and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.